Patent details

Basic Information

Publication number:

EP3046901

PCT Application Number:

AU2014000923

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148453731

PCT Publication Number:

WO2015039173

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS

French Title of Invention:

COMPOSITIONS POUR LE TRAITEMENT DE L'HYPERTENSION ET/OU D'UNE FIBROSE

German Title of Invention:

ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON BLUTHOCHDRUCK UND/ODER FIBROSE

SPC Number:

Dates

Filing date:

17/09/2014

Grant date:

18/10/2017

EP Publication Date:

27/07/2016

PCT Publication Date:

26/03/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/10/2017

EP B1 Publication Date:

18/10/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/09/2018

Expiration date:

17/09/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/10/2017

 

 

Name:

Vectus Biosystems Limited

Address:

3-11 Primrose Avenue, Rosebery, NSW 2018, Australia (AU)

Inventor

Name:

DUGGAN, Karen Annette

Address:

Australia (AU)

Priority

Priority Number:

2013903573

Priority Date:

17/09/2013

Priority Country:

Australia (AU)

Classification

IPC classification:

A61K 31/165; A61P 9/12; A61P 13/12; C07C 235/34;

Publication

European Patent Bulletin

Issue number:

201742

Publication date:

18/10/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/01/2019	Outgoing Correspondence	1